-
SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.Börse NasdaqISIN US24984K1051
Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:
1.938.020.736 oder 984.000.000
Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:
60 oder 278 Mitarbeiter
DermTech underperformed den DAX um -22 % vom 10.08.2017 bis 18.06.2021
Die letzten Quartalsergebnisse Erwarteter Gewinn je Aktie beim aktuellen Wert von 41,26 USD +0,09%
Portrait der DermTech Aktie
Das Unternehmen DermTech, Inc aus USA beschäftigt 169 Mitarbeiter und ist in den Bereichen Chemie & Pharma, Gesundheitsdienstleistungen tätig.
Die DermTech Aktie konnte seit dem 10.08.2017 eine Rendite von 10% erwirtschaften.
Das Unternehmen DermTech, Inc ist nur in 2 ETFs enthalten und somit eine sehr unbekannte Aktie. Der Spitzenreiter iShares Healthcare Innovation UCITS ETF gewichtet DermTech mit 0,16% im ETF.
ETFs die in DermTech, Inc investieren
Dir gefallen die Informationen zu DermTech?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:
Dir gefallen die Informationen zu DermTech?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:
Dir gefallen die Informationen zu DermTech?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:
Dir gefallen die Informationen zu DermTech?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:
38 News & Informationen zur DermTech Aktie
DermTech (DMTK) Shares Cross Above 200 DMA
DermTech, Inc. 2021 Q2 – Results – Earnings Call Presentation (NASDAQ:DMTK)
The following slide deck was published by DermTech, Inc.
DermTech, Inc. (DMTK) CEO John Dobak on Q2 2021 Results – Earnings Call Transcript
DermTech, Inc. (NASDAQ:DMTK) Q2 2021 Earnings Conference Call August 04, 2021, 16:30 ET Company Participants Caroline Corner – IR John Dobak – President, CEO & Director Kevin Sun – CFO,…
DermTech, Inc. (DMTK) Reports Q2 Loss, Tops Revenue Estimates
DermTech, Inc. (DMTK) delivered earnings and revenue surprises of 11.11% and 11.39%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Avalon Advisors, Llc Buys Gilead Sciences Inc, Intel Corp, FedEx Corp, Sells Albemarle Corp, Garmin, The Estee Lauder Inc
GuruFocus Article or News written by insider and the topic is about:
Were Hedge Funds Right About DermTech, Inc. (DMTK)?
Out of thousands of stocks that are currently traded on the market, it is difficult to identify those that will really generate strong returns. Hedge…
DermTech Finds New Headquarters
DermTech Announces New San Diego Headquarters
DermTech, Inc. DMTK (“DermTech” or the “Company”), a leader in precision dermatology enabled by a non-invasive skin genomics platform, announced expansion
3 Healthcare Stocks That Could Make You Rich
They're disruptors that could change healthcare.
Sargent Bickham Lagudis LLC Buys Schwab U.S. Large-Cap Value ETF, iShares Core Conservative Allocation ETF, Schwab US Dividend Equity ETF, Sells Schwab Emerging Markets Equity ETF, iShares Core MSCI E
GuruFocus Article or News written by insider and the topic is about:
Where Do Hedge Funds Stand On CSG Systems International, Inc. (CSGS)?
The 800+ hedge funds and famous money managers tracked by Insider Monkey have already compiled and submitted their 13F filings for the first quarter,…
Where Do Hedge Funds Stand On PMV Pharmaceuticals, Inc. (PMVP)?
Many prominent investors, including Warren Buffett, David Tepper and Stan Druckenmiller, have been cautious regarding the current bull market and missed…
This Medical Device Company Is Changing the Game in Skin Cancer
And it's on sale right now.
Certara Appoints Nancy Killefer and Cynthia Collins as New Independent Board Members
PRINCETON, N.J., July 15, 2021 — Certara, a global leader in biosimulation, today announced the appointments of Nancy Killefer and Cynthia Collins to its board of directors, effective… | July 15, 2021
Certara Appoints Nancy Killefer and Cynthia Collins as New Independent Board Members
PRINCETON, N.J., July 15, 2021 (GLOBE NEWSWIRE) — Certara, a global leader in biosimulation, today announced the appointments of Nancy Killefer and…
Certara Appoints Nancy Killefer And Cynthia Collins As New Independent Board Members
PRINCETON, N.J., July 15, 2021 (GLOBE NEWSWIRE) — Certara, a global leader in biosimulation, today announced the appointments of Nancy Killefer and Cynthia
Should I Avoid Groupon Inc (GRPN)?
The Insider Monkey team has completed processing the quarterly 13F filings for the March quarter submitted by the hedge funds and other money managers…
Why Jim Cramer Has Such a Positive Outlook for the Rest of 2021 – 24
24/7 Wall St. takes a look at famed market personality Jim Cramer’s latest buy and sell recommendations and overall analysis.
Cormorant Asset Management, LLC Buys Design Therapeutics Inc, Edgewise Therapeutics Inc, Tarsus Pharmaceuticals Inc, Sells Beam Therapeutics Inc, Immunovant Inc,
GuruFocus Article or News written by insider and the topic is about:
DermTech CEO John Dobak, M.D. Wins San Diego Business Journal CEO of the Year Award, Public Company, Medium Category
DermTech, Inc. (NASDAQ: DMTK) (“DermTech”), a leader in precision dermatology enabled by a non-invasive skin genomics platform, announced today that D
Ditch Dogecoin: These 3 Stocks Could Double Your Money
The path to a twofold or greater return is straightforward for each of these stocks.
DermTech To Partner With University Of Barcelona For Research Study On Atopic Dermatitis And Psoriasis
DermTech, Inc. DMTK (“DermTech”), a leader in precision dermatology enabled by a non-invasive skin genomics platform, announced today a collaboration with
DermTech Stock: Disrupting Skin Cancer Testing (NASDAQ:DMTK)
DermTech has created a patch to disrupt the skin cancer detection market, but there are risks about valuation, commercialization, and DermTech's financials that give me pause.
Dermtech Inc (DMTK) CEO John Dobak Sold $1.2 million of Shares
Dermtech Inc (DMTK) CEO John Dobak Sold $1.2 million of Shares, Stocks: DMTK, release date:Apr 14, 2021
Notable Insider Buys Of The Past Week: Conagra Brands Plus Plenty Of Biotech Activity
Insider buying can be an encouraging signal for potential investors, especially when markets face uncertainty. Insiders were taking advantage of …
Notable Insider Buys Of The Past Week: Conagra Brands Plus Plenty Of Biotech Activity
Insider buying can be an encouraging signal for potential investors, especially when markets face uncertainty.
Insiders were taking advantage of secondary …
DermTech (DMTK) Investor Presentation – Slideshow (NASDAQ:DMTK)
The Daily Biotech Pulse: DBV's Positive FDA Feedback, Pfizer's Cancer Drug Gets Label Expansion, Applied DNA COVID Testing Volume Surges
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Jan. 14) 10X …
DermTech Pigmented Lesion Assay (PLA) to Enrich Melanoma Positivity Nearly Five-Fold in Biopsied Lesions: Findings from a Large US Registry
DermTech, Inc. , a leader in precision dermatology enabled by a non-invasive skin genomics platform, announced today that SKIN has published the results of a large registry study finding that the… | January 14, 2021
The Daily Biotech Pulse: Alexion Pauses COVID-19 Study, NantKwest Readout, Organogenesis Jumps On Guidance, Trial Updates
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Ja…
80 Biggest Movers From Yesterday
Gainers Live Ventures Incorporated (NASDAQ:LIVE) shares jumped 90.4% to close at $23.90 on Wednesday after the company swung to a profit in the …
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers
Organogenesis Holdings (NASDAQ:ORGO) stock rose 28.47% to $9.43 during Wednesday's after-market session. Organogenesis Holdings's trading …
The Daily Biotech Pulse: Bausch Health Issues Positive Pre-Announcement, Acorda Streamlines Operations
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Jan. 12) …
45 Stocks Moving in Wednesday's Pre-Market Session
Gainers Summit Midstream Partners, LP (NYSE:SMLP) shares rose 58.3% to $21.67 in pre-market trading after the company reported achievement of ke…
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers
Biolase (NASDAQ:BIOL) stock rose 22.11% to $1.27 during Tuesday's after-market session. At the close, Biolase's trading volume reached 14.5 …
The Daily Biotech Pulse: Sarepta Gene Therapy Study Readout, Novavax Vaccine Supply Deal, 2 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Jan. 7) …
12 Health Care Stocks Moving In Wednesday’s After-Market Session
Gainers
Apollo Endosurgery (NASDAQ:APEN) shares increased by 5.62% to $3.74 during Wednesday’s after-market session. Apollo Endosurgery’s trading …
DermTech Shares Rise 32% on Geisinger Health Support for Skin Cancer Test